Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer's breast cancer drug combo falls short of survival goal
Yahoo/Reuters
Mon, 06/25/18 - 12:42 pm
Tags:
Pfizer, breast cancer, Ibrance, clinical trials
Naturally-Derived Cancer Drugs Provide Clues As To How Microbiome May Cause Chemotherapy Resistance
Forbes
Fri, 06/22/18 - 10:18 am
Tags:
Pfizer, Mylotarg, Besponsa, chemotherapy, cancer, microbiome
Myriad Genetics Wins FDA SPMA Nod for BRACAnalysis CDx
Yahoo/Zacks.com
Tue, 06/19/18 - 10:19 pm
Tags:
Myriad Genetics, FDA, BRACAnalysis CDx, diagnostics, Pfizer, talazoparib
Cash for NASH: 2 Top Biotech Takeover Targets and 3 Potential Buyers
Motley Fool
Fri, 06/15/18 - 07:04 pm
Tags:
NASH, liver disease, Viking Therapeutics, Madrigal Pharmaceuticals, Pfizer, Bristol-Myers Squibb, Gilead Sciences
ViiV Healthcare reports positive results for late-stage HIV trials
Marketwatch
Thu, 06/14/18 - 09:19 am
Tags:
ViiV Healthcare, GSK, Pfizer, Shionogi, HIV, clinical trials, Dolutegravir, lamivudine
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report
Fierce Pharma
Tue, 06/12/18 - 11:22 am
Tags:
GSK, Merck, Sanofi, Pfizer, Novavax, vaccines
Can This Pharma's $14 Billion Bet Succeed?
Motley Fool
Tue, 06/12/18 - 09:39 am
Tags:
Pfizer, M&A, Medivation, Xtandi, talazoparib
A Story Of Devastation And Rebirth -- The Former Pfizer Research Labs In Ann Arbor
Forbes
Mon, 06/11/18 - 09:34 am
Tags:
Pfizer, Torcetrapib, R&D, Lipitor
Pfizer wins appeal against UK fine for epilepsy drug price hike
Yahoo/Reuters
Thu, 06/7/18 - 10:46 pm
Tags:
Pfizer, Flynn Pharma, epilepsy, drug pricing, CMA
Pfizer's PARP Inhibitor Talazoparib Gets FDA Priority Review and EMA Submission
CP Wire
Thu, 06/7/18 - 09:45 am
Tags:
Pfizer, talazoparib, BRCA-mutant breast cancer, breast cancer, metastatic breast cancer, FDA, EMA, priority review
Thu, 06/7/18 - 09:34 am
Tags:
Pfizer, talazoparib, BRCA-mutant breast cancer, breast cancer
Pfizer adds $600M to its venture group, with a special focus on the neurosciences field it just retreated from
Endpoints
Wed, 06/6/18 - 11:29 am
Tags:
Pfizer, Neurosciences, R&D, venture funds
BIO18: Pfizer's Bourla on volume vs. value
Biopharma Dive
Mon, 06/4/18 - 10:04 pm
Tags:
patients, Albert Bourla, Pfizer, BIO 2018
Pfizer Receives Good News for Trazimera (trastuzumab) Biosimilar
CP Wire
Fri, 06/1/18 - 10:10 am
Tags:
Pfizer, CHMP, Europe, EMA, Trazimera, trastuzumab, biosimilars, Herceptin
Pfizer's Xeljanz jumps into ulcerative colitis fray with best-case FDA approval
Fierce Pharma
Thu, 05/31/18 - 10:58 am
Tags:
Pfizer, Xeljanz, FDA, ulcerative colitis
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
Endpoints
Tue, 05/29/18 - 09:22 pm
Tags:
M&A, JNJ, Merck, Pfizer, Gilead Sciences, Amgen, Biogen, Takeda, Regeneron, Alexion
FDA Grants Pfizer's Xalkori Breakthrough Therapy Status for Two New Indications
CP Wire
Tue, 05/29/18 - 10:37 am
Tags:
Pfizer, Xalkori, metastatic non-small cell lung cancer, FDA, breakthrough therapies, anaplastic large-cell lymphoma
Tue, 05/29/18 - 10:14 am
Tags:
Pfizer, Xalkori, non-small cell lung cancer, anaplastic large-cell lymphoma
Pfizer lies behind Mylan’s issues with Epipen
GoinPharma
Mon, 05/28/18 - 01:29 pm
Tags:
Mylan Labs, EpiPens, drug shortage, Pfizer
Kickback Allegation Settlements Pile Up for Pharmaceutical Companies
RAPS.org
Sat, 05/26/18 - 09:19 am
Tags:
kickbacks, Medicare, physicians, Pfizer, Jazz Pharmaceuticals, Valeant Pharmaceuticals, Shire, Omnicare

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.